JGC
KZIA

J. Goldman & Co’s Kazia Therapeutics KZIA Stock Holding History

J. Goldman & Co’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$964K Buy
+68,491
New +$834K 0.02% 469

Other funds holding KZIA

BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

J. Goldman & Co's KZIA Position: Q2 2026 in Review

J. Goldman & Co opened a new position in Kazia Therapeutics (KZIA) in Q2 2026: 68,491 shares worth $964K. The stake represents 0.02% of the portfolio and ranks #469 among its holdings.

36 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • J. Goldman & Co held 68,491 shares of Kazia Therapeutics worth $964K as of Q2 2026.
  • Kazia Therapeutics was a new J. Goldman & Co position in Q2 2026.
  • Kazia Therapeutics made up 0.02% of J. Goldman & Co's portfolio in Q2 2026, its #469 holding.
  • 36 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.